Early research (Phase 1)UnknownNCT05270772What this trial is testingCAR-T-19 Cells for Patients With CD19+ Relapse/Refractory B-ALLWho this might be right forCD19+ Relapse/Refractory B-ALL Chinese PLA General Hospital 9
Testing effectiveness (Phase 2)UnknownNCT05429905What this trial is testingDual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage LeukaemiaWho this might be right forLymphoblastic LeukemiaLymphoblastic Leukemia, Acute, ChildhoodLymphoblastic Leukemia in Children+2 more KK Women's and Children's Hospital 48
Large-scale testing (Phase 3)Active Not RecruitingNCT05602194What this trial is testingStudying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or LymphomaWho this might be right forB Acute Lymphoblastic LeukemiaB Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1B Acute Lymphoblastic Leukemia, BCR-ABL1-Like+3 more Children's Oncology Group 440
Testing effectiveness (Phase 2)Looking for participantsNCT06213636What this trial is testingFourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL).Who this might be right forAcute Lymphoblastic Leukemia, Adult B-CellAcute Lymphoblastic Leukemia, in RelapseNon-Hodgkin Lymphoma, B-cell+4 more Essen Biotech 75
Testing effectiveness (Phase 2)WithdrawnNCT01101412What this trial is testingAntimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With MalignanciesWho this might be right forChronic Myeloproliferative DisordersInfectionLeukemia+6 more M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT04788472What this trial is testingSequential CD19 and CD22 CAR-T Therapy for Newly Diagnosed Ph+ B-ALLWho this might be right forB-Cell Acute Lymphoblastic Leukemia, Adult Zhejiang University 28
Not applicableEnded earlyNCT00038883What this trial is testingCampath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid MalignanciesWho this might be right forLeukemia, Lymphocytic, ChronicLeukemia, Lymphocytic, AcuteLymphoma, Low-Grade+2 more M.D. Anderson Cancer Center 19
Testing effectiveness (Phase 2)Study completedNCT00001637What this trial is testingImmunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older AdultsWho this might be right forChronic Lymphocytic LeukemiaGraft vs Host DiseaseLeukemia+2 more National Heart, Lung, and Blood Institute (NHLBI) 28
Testing effectiveness (Phase 2)Study completedNCT00004145What this trial is testingChemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more University of Chicago 16
Testing effectiveness (Phase 2)Study completedNCT02988466What this trial is testingReduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCTWho this might be right forHematologic Malignancies Masonic Cancer Center, University of Minnesota 78
Early research (Phase 1)Study completedNCT00107354What this trial is testingCellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell TransplantWho this might be right forLeukemiaMyelodysplastic Syndromes Fred Hutchinson Cancer Center
Very early researchNot Yet RecruitingNCT07256353What this trial is testingAllogeneic UCB-derived CAR-T for B-ALLWho this might be right forB-Cell Acute Lymphoblastic Leukemia, Adult The General Hospital of Western Theater Command 50
Testing effectiveness (Phase 2)Looking for participantsNCT06918431What this trial is testingAsparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaWho this might be right forB Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeLymphoblastic Lymphoma City of Hope Medical Center 53
Not applicableStudy completedNCT02767388What this trial is testingElectrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and RecoveryWho this might be right forMyelodysplastic SyndromeEffects of ChemotherapyMild Cognitive Impairment+6 more University of Nebraska 45
Testing effectiveness (Phase 2)Study completedNCT00014469What this trial is testingCombination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00027820What this trial is testingTotal-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerWho this might be right forAdult Acute Myeloid Leukemia in RemissionChildhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in Remission+27 more Fred Hutchinson Cancer Center 106
Testing effectiveness (Phase 2)Study completedNCT00309842What this trial is testingMyeloablative Umbilical Cord Blood Transplantation in Hematological DiseasesWho this might be right forAcute Myeloid LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+10 more Masonic Cancer Center, University of Minnesota 213
Early research (Phase 1)Study completedNCT00569283What this trial is testingDonor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow TransplantWho this might be right forCancer Asan Medical Center 18
Testing effectiveness (Phase 2)UnknownNCT06111625What this trial is testingShort-term Blinatumomab as a Bridge Therapy for Allo-HSCT in Low Burden B-ALLWho this might be right forLeukemia, Lymphoid Sichuan University 20
Very early researchLooking for participantsNCT04532281What this trial is testingMurine CD19 CAR-T Therapy for Patients With Relapsed or Refractory CD19+ B-cell Hematological MalignanciesWho this might be right forAcute Lymphoblastic LeukemiaNon-Hodgkin Lymphoma of Soft Tissue Zhejiang University 120